Neuroscience Update by LucidQuest Episode 25 скачать в хорошем качестве

Neuroscience Update by LucidQuest Episode 25

🧠 This Week in Neuroscience: MS Genetics Breakthrough, $372.5M CNS Funding, AI for Drug Discovery, and More Explore the latest developments shaping neuroscience, neurology, and rare CNS disease research. This week’s update spans cutting-edge MS genetic risk research, major investment in precision CNS therapies, AI-powered drug permeability predictions, and diagnostic tools redefining metastatic cancer detection in the brain. Plus, FDA priority review for Hunter syndrome therapy, Canadian approval for a pediatric seizure rescue med, and a compelling awareness film on myasthenia gravis. 📌 What’s Inside This Week’s Update 🧬 MS Australia funds EBV-genetic risk research in multiple sclerosis 💊 BioNxt secures patents for sublingual Cladribine MS therapy ✂️ FDA grants orphan drug status to Duchenne MD gene-editing therapy 🧠 MapLight raises $372.5M for CNS precision drug pipeline 🧪 Plus Therapeutics launches CNSide test with ninety-two percent sensitivity and ninety-five percent specificity 🚀 FDA priority review for Denali’s Hunter syndrome brain-penetrant therapy 🤖 Lantern Pharma launches AI tool with ninety-four percent accuracy in BBB permeability prediction 🎥 Alexion premieres Rare Connections myasthenia gravis awareness film 🇨🇦 Health Canada approves Buccolam® pediatric seizure rescue med ⚡ Cassava reports positive preclinical data for simufilam in TSC-related epilepsy From regulatory wins to AI-driven drug discovery, this week’s roundup spotlights the innovations advancing neuroscience care and research. 📢 Stay Ahead in Neuroscience Research! ✅ Like, share, and subscribe for weekly updates on neuroscience, neurology, and rare CNS diseases 🌐 Visit www.lqventures.com for expert healthcare insights and consulting services 📩 Contact LucidQuest at [email protected] for strategic guidance on neuroscience innovations and clinical research 🔔 Turn on notifications so you never miss an update! #Neuroscience #MultipleSclerosis #GeneTherapy #HunterSyndrome #MyastheniaGravis #AIinHealthcare #EpilepsyResearch #RareDiseases #NeuroUpdates #LucidQuest #ClinicalTrials #FDAupdates #BiotechNews #HealthcareInnovation